239 related articles for article (PubMed ID: 24495468)
1. Melatonin reduces tachycardia in postural tachycardia syndrome: a randomized, crossover trial.
Green EA; Black BK; Biaggioni I; Paranjape SY; Bagai K; Shibao C; Okoye MC; Dupont WD; Robertson D; Raj SR
Cardiovasc Ther; 2014 Jun; 32(3):105-12. PubMed ID: 24495468
[TBL] [Abstract][Full Text] [Related]
2. Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more.
Raj SR; Black BK; Biaggioni I; Paranjape SY; Ramirez M; Dupont WD; Robertson D
Circulation; 2009 Sep; 120(9):725-34. PubMed ID: 19687359
[TBL] [Abstract][Full Text] [Related]
3. Effects of norepinephrine reuptake inhibition on postural tachycardia syndrome.
Green EA; Raj V; Shibao CA; Biaggioni I; Black BK; Dupont WD; Robertson D; Raj SR
J Am Heart Assoc; 2013 Sep; 2(5):e000395. PubMed ID: 24002370
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic profiles and tolerability of modafinil in the treatment of postural tachycardia syndrome: a randomized, placebo-controlled trial.
Kpaeyeh J; Mar PL; Raj V; Black BK; Arnold AC; Biaggioni I; Shibao CA; Paranjape SY; Dupont WD; Robertson D; Raj SR
J Clin Psychopharmacol; 2014 Dec; 34(6):738-41. PubMed ID: 25222185
[TBL] [Abstract][Full Text] [Related]
5. Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrome.
Coffin ST; Black BK; Biaggioni I; Paranjape SY; Orozco C; Black PW; Dupont WD; Robertson D; Raj SR
Heart Rhythm; 2012 Sep; 9(9):1484-90. PubMed ID: 22561596
[TBL] [Abstract][Full Text] [Related]
6. Acute hemodynamic effects of a selective serotonin reuptake inhibitor in postural tachycardia syndrome: a randomized, crossover trial.
Mar PL; Raj V; Black BK; Biaggioni I; Shibao CA; Paranjape SY; Dupont WD; Robertson D; Raj SR
J Psychopharmacol; 2014 Feb; 28(2):155-61. PubMed ID: 24227635
[TBL] [Abstract][Full Text] [Related]
7. Postural tachycardia syndrome and inappropriate sinus tachycardia: role of autonomic modulation and sinus node automaticity.
Nwazue VC; Paranjape SY; Black BK; Biaggioni I; Diedrich A; Dupont WD; Robertson D; Raj SR
J Am Heart Assoc; 2014 Apr; 3(2):e000700. PubMed ID: 24721800
[TBL] [Abstract][Full Text] [Related]
8. A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropathic compared with hyperadrenergic postural tachycardia syndrome.
Ross AJ; Ocon AJ; Medow MS; Stewart JM
Clin Sci (Lond); 2014 Feb; 126(4):289-96. PubMed ID: 23978222
[TBL] [Abstract][Full Text] [Related]
9. Clinical presentation and management of patients with hyperadrenergic postural orthostatic tachycardia syndrome. A single center experience.
Kanjwal K; Saeed B; Karabin B; Kanjwal Y; Grubb BP
Cardiol J; 2011; 18(5):527-31. PubMed ID: 21947988
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort.
Reynolds GK; Lewis DP; Richardson AM; Lidbury BA
J Intern Med; 2014 Apr; 275(4):409-17. PubMed ID: 24206536
[TBL] [Abstract][Full Text] [Related]
11. Postural tachycardia syndrome: a heterogeneous and multifactorial disorder.
Benarroch EE
Mayo Clin Proc; 2012 Dec; 87(12):1214-25. PubMed ID: 23122672
[TBL] [Abstract][Full Text] [Related]
12. Understanding the placebo effect in clinical trials for postural tachycardia syndrome.
Nwazue VC; Arnold AC; Raj V; Black BK; Biaggioni I; Paranjape SY; Orozco C; Dupont WD; Robertson D; Raj SR
Clin Exp Pharmacol Physiol; 2014 May; 41(5):325-30. PubMed ID: 24606242
[TBL] [Abstract][Full Text] [Related]
13. Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome.
Raj SR; Black BK; Biaggioni I; Harris PA; Robertson D
Circulation; 2005 May; 111(21):2734-40. PubMed ID: 15911704
[TBL] [Abstract][Full Text] [Related]
14. Effect of High Dietary Sodium Intake in Patients With Postural Tachycardia Syndrome.
Garland EM; Gamboa A; Nwazue VC; Celedonio JE; Paranjape SY; Black BK; Okamoto LE; Shibao CA; Biaggioni I; Robertson D; Diedrich A; Dupont WD; Raj SR
J Am Coll Cardiol; 2021 May; 77(17):2174-2184. PubMed ID: 33926653
[TBL] [Abstract][Full Text] [Related]
15. Diurnal variability in orthostatic tachycardia: implications for the postural tachycardia syndrome.
Brewster JA; Garland EM; Biaggioni I; Black BK; Ling JF; Shibao CA; Robertson D; Raj SR
Clin Sci (Lond); 2012 Jan; 122(1):25-31. PubMed ID: 21751966
[TBL] [Abstract][Full Text] [Related]
16. Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syndrome.
Taub PR; Zadourian A; Lo HC; Ormiston CK; Golshan S; Hsu JC
J Am Coll Cardiol; 2021 Feb; 77(7):861-871. PubMed ID: 33602468
[TBL] [Abstract][Full Text] [Related]
17. Malmö POTS symptom score: Assessing symptom burden in postural orthostatic tachycardia syndrome.
Spahic JM; Hamrefors V; Johansson M; Ricci F; Melander O; Sutton R; Fedorowski A
J Intern Med; 2023 Jan; 293(1):91-99. PubMed ID: 36111700
[TBL] [Abstract][Full Text] [Related]
18. Reduced cerebral blood flow with orthostasis precedes hypocapnic hyperpnea, sympathetic activation, and postural tachycardia syndrome.
Del Pozzi AT; Schwartz CE; Tewari D; Medow MS; Stewart JM
Hypertension; 2014 Jun; 63(6):1302-8. PubMed ID: 24711524
[TBL] [Abstract][Full Text] [Related]
19. Altered sympathetic nervous reactivity and norepinephrine transporter expression in patients with postural tachycardia syndrome.
Lambert E; Eikelis N; Esler M; Dawood T; Schlaich M; Bayles R; Socratous F; Agrotis A; Jennings G; Lambert G; Vaddadi G
Circ Arrhythm Electrophysiol; 2008 Jun; 1(2):103-9. PubMed ID: 19808400
[TBL] [Abstract][Full Text] [Related]
20. The complexity of diagnosing postural orthostatic tachycardia syndrome: influence of the diurnal variability.
Moon J; Lee HS; Byun JI; Sunwoo JS; Shin JW; Lim JA; Kim TJ; Shin YW; Lee KJ; Jeon D; Jung KH; Lee ST; Jung KY; Chu K; Lee SK
J Am Soc Hypertens; 2016 Mar; 10(3):263-70. PubMed ID: 26857333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
